Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany

Clinical Research in Cardiology

Volumn 95, Issue 8, 2006, Pages 405-412

  Bischoff, B ^a   Silber, Sigmund ^a   Richartz, B M ^a   Pieper, L ^b   Klotsche, J ^b   Wittchen, H U ^b  

^a Cardiology Practice and Hospital   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Coronary heart disease; Prevalence; Primary care; Secondary prevention

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; FEMALE; GERMANY; HEART INFARCTION; HUMAN; LONG TERM CARE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY MEDICAL CARE; PRIVATE HEALTH INSURANCE; REVASCULARIZATION; RISK REDUCTION; SECONDARY PREVENTION; SOCIAL INSURANCE; STABLE ANGINA PECTORIS;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR AGENTS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIANS, FAMILY; PREVALENCE; PROSPECTIVE STUDIES;

EID: 33746529910     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-0399-2     Document Type: Article

References (27)

1. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D (2003) Executive Summary: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (executive summary). Eur Heart J 24:1601-1610
2. Koenig W (1998) Epidemiology of coronary heart disease. Z Kardiol 87(Suppl 2):3-7
3. Statistisches Bundesamt Deutschland (2005) http://www.destatis.de
4. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W (2005) Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26:804-847
5. Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W (2005) Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J 26:1169-1179
6. Daly CA, Clemens F, Sendon JL, Tavazzi L, Boersma E, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheugt F, Fox KM (2005) The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur Heart J 26:1011-1022
7. Wittchen HU, Glaesmer H, März W, Stalla G, Lehnert H, Zeiher AM, Silber S, Koch U, Böhler S, Pittrow D, Ruf G (2005) Cardiovascular risk factors in primary care: methods and baseline prevalence rates - the DETECT program. Curr Med Res Opin 21:619-630
8. Böhler S, Glaesmer H, Pittrow D, Lehnert H, Stalla GK, Zeiher AM, März W, Silber S, Wehling M, Ruf G, Reinecke A, Wittchen HU (2004) Diabetes and cardiovascular risk evaluation and management in primary care: progress and unresolved issues - rationale for a nationwide primary care project in Germany. Exp Clin Endocrinol Diabetes 112:157-170
9. StataCorp., Stata Statistical Software, Release 8.0 (2003) College Station, TX: Stata Corporation
10. Knopf H (2004) Arzneimittelanwendung bei Frauen und Männern mit koronarer Herzkrankheit. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 47:1051-1056
11. Equinox Group (2001) Stable Angina Epidemiology. Equinox Drug Assessment Library
12. Jaber WA, Lennon RJ, Mathew V, Holmes DR Jr, Lerman A, Rihal CS (2005) Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator. J Am Coll Cardiol 46:1473-1478
13. Silber S, Krischke I, Prohaska M (2000) Undertreatment in secondary prevention of patients with coronary heart disease after revascularization. Herz 25:623-626
14. The EUROASPIRE I and II Group (2001) Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 357:995-1001
15. Brady AJB, Oliver MA, Pittard JB (2001) Secondary prevention in 24431 patients with coronary heart disease: survey in primary care. BMJ 322:1463
16. Abuful A, Gidron Y, Henkin Y (2005) Physician's attitudes toward preventive therapy for coronary artery disease: Is there a gender bias? Clinical Cardiology 28(8):389-393
17. Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A (2001) Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ 322:832
18. Sheifer SE, Escarce JJ, Schulman KA (2000) Race and sex differences in the management of coronary artery disease. American Heart Journal 139(5):848-857
19. Schwartz JB (2003) Gender-specific implications for cardiovascular medication use in the elderly optimizing therapy for older women. Cardiol Rev 11:275-298
20. Os I, Bratland B, Dahlhof B, Gisholt K, Syvertsen JO, Tretli S (1994) Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 7(11):1012-1015
21. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, Brogan GXJ, Boden WE, Roe MT, Ohman EM, Gibler WB, Newby LK, CRUSADE I (2005) Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 45(6):832-837
22. Doyle F, De La Harpe D, McGee H, Shelley E, Conroy R (2005) Gender differences in the presentation and management of acute coronary syndromes: a national sample of 1365 admissions. Eur J Cardiovasc Prev Rehabil 12(4):376-379
23. Heer T, Schiele R, Schneider S, Gitt AK, Wienbergen H, Gottwik M, Gieseler U, Voigtlander T, Hauptmann KE, Wagner S, Senges J (2002) Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol 89(5):511-517
24. Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, Dubé R, Taleghani CK, Burke JE, Williams S, Eisenberg JM, Escarce JJ, Ayers W (1999) The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 25; 340(8):618-626
25. Bertoni AG, Bonds DE, Lovato J, Goff DC, Brancati FL (2004) Sex disparities in procedure use for acute myocardial infarction in the United States, 1995 to 2001. Am Heart J 147(6):1054-1060
26. Yu BR (2005) Influences of health insurance status on clinical treatments and outcomes for 4714 patients after acute myocardial infarction in 14 Chinese general hospitals. J Med Dent Sci 52(2):143-151
27. Hiestand BC, Prall DM, Lindsell CJ, Hoekstra JW, Pollack CV, Hollander JE, Tiffany BR, Peacock WF, Diercks DB, Gibler WB (2004) Insurance status and the treatment of myocardial infarction at academic centers. Acad Emerg Med 11(4):343-348